Published in Pediatrics on June 09, 2008
Computerized Cognitive Rehabilitation in Children After Severe Malaria (CM_CCRT) | NCT01743417
Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol (2010) 3.47
High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria. Clin Infect Dis (2014) 2.02
Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res (2010) 1.98
The neuropathology of fatal cerebral malaria in malawian children. Am J Pathol (2011) 1.79
Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis (2011) 1.52
Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am J Pathol (2010) 1.51
Diagnosis and management of the neurological complications of falciparum malaria. Nat Rev Neurol (2009) 1.50
Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res Notes (2010) 1.37
Socioeconomic predictors of cognition in Ugandan children: implications for community interventions. PLoS One (2009) 1.25
Immediate neuropsychological and behavioral benefits of computerized cognitive rehabilitation in Ugandan pediatric cerebral malaria survivors. J Dev Behav Pediatr (2009) 1.23
The 'hidden' burden of malaria: cognitive impairment following infection. Malar J (2010) 1.23
Asymptomatic Plasmodium infection and cognition among primary schoolchildren in a high malaria transmission setting in Uganda. Am J Trop Med Hyg (2013) 1.21
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther (2010) 1.20
Malaria in school-age children in Africa: an increasingly important challenge. Trop Med Int Health (2014) 1.19
Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog (2010) 1.18
Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. J Infect Dis (2011) 1.16
HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS (2010) 1.16
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog (2012) 1.11
Developmental outcomes in Malawian children with retinopathy-positive cerebral malaria. Trop Med Int Health (2010) 1.11
A preliminary examination of the construct validity of the KABC-II in Ugandan children with a history of cerebral malaria. Afr Health Sci (2009) 1.09
Severe malarial anemia is associated with long-term neurocognitive impairment. Clin Infect Dis (2014) 1.07
Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials (2011) 1.06
Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria. PLoS One (2011) 1.03
Rosiglitazone modulates the innate immune response to Plasmodium falciparum infection and improves outcome in experimental cerebral malaria. J Infect Dis (2009) 1.03
Global research priorities for infections that affect the nervous system. Nature (2015) 1.01
Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour. Malar J (2011) 1.00
Impaired everyday memory associated with encephalopathy of severe malaria: the role of seizures and hippocampal damage. Malar J (2009) 1.00
Persistent cognitive and motor deficits after successful antimalarial treatment in murine cerebral malaria. Microbes Infect (2010) 1.00
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India. Malar J (2011) 0.99
Non-heat related impacts of climate change on working populations. Glob Health Action (2010) 0.97
Reliability of the Luganda version of the Child Behaviour Checklist in measuring behavioural problems after cerebral malaria. Child Adolesc Psychiatry Ment Health (2009) 0.96
Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol. Malar J (2010) 0.95
Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One (2013) 0.94
A brief assessment of learning for orphaned and abandoned children in low and middle income countries. AIDS Behav (2012) 0.93
Association between early childhood exposure to malaria and children's pre-school development: evidence from the Zambia early childhood development project. Malar J (2013) 0.92
Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria. Antimicrob Agents Chemother (2011) 0.92
Atypical brain response to novelty in rural African children with a history of severe falciparum malaria. J Neurol Sci (2010) 0.91
Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model. Malar J (2012) 0.90
Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale. Med Hypotheses (2011) 0.89
The association between cognition and academic performance in Ugandan children surviving malaria with neurological involvement. PLoS One (2013) 0.88
Cognition, behaviour and academic skills after cognitive rehabilitation in Ugandan children surviving severe malaria: a randomised trial. BMC Neurol (2011) 0.88
Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria. Malar J (2012) 0.87
Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV. J Acquir Immune Defic Syndr (2014) 0.85
Cerebral malaria retinopathy predictors of persisting neurocognitive outcomes in Malawian children. Pediatr Infect Dis J (2014) 0.85
Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain. PLoS One (2013) 0.84
Statistical Approaches to Assess the Effects of Disease on Neurocognitive Function Over Time. J Biom Biostat (2012) 0.84
Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents. Expert Rev Anti Infect Ther (2012) 0.83
Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria. Malar J (2013) 0.83
Cerebral tissue oxygenation impairment during experimental cerebral malaria. Virulence (2013) 0.83
PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria. PLoS Pathog (2014) 0.82
Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice. Exp Parasitol (2010) 0.82
Cerebral malaria: gamma-interferon redux. Front Cell Infect Microbiol (2014) 0.81
A new hypothesis on the manifestation of cerebral malaria: the secret is in the liver. Med Hypotheses (2013) 0.81
Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines. Free Radic Biol Med (2013) 0.81
Use of the Behavior Rating Inventory of Executive Function and Child Behavior Checklist in Ugandan Children with HIV or a History of Severe Malaria. J Dev Behav Pediatr (2015) 0.81
In vitro sensitivity of Plasmodium falciparum field isolates to extracts from Cameroonian Annonaceae plants. Parasitol Res (2011) 0.80
Clinical Comparison of Retinopathy-Positive and Retinopathy-Negative Cerebral Malaria. Am J Trop Med Hyg (2017) 0.79
Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment. PLoS One (2012) 0.79
Evidence of Endothelial Activation in Asymptomatic Plasmodium falciparum Parasitemia and Effect of Blood Group on Levels of von Willebrand Factor in Malaria. J Pediatric Infect Dis Soc (2012) 0.79
Vascular dysfunction as a target for adjuvant therapy in cerebral malaria. Mem Inst Oswaldo Cruz (2014) 0.79
Pathophysiological Mechanisms in Gaseous Therapies for Severe Malaria. Infect Immun (2016) 0.79
From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria. Malar J (2015) 0.79
The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria. PPAR Res (2011) 0.78
Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives. Malar J (2016) 0.78
Reducing neurodevelopmental disorders and disability through research and interventions. Nature (2015) 0.78
Neurocognitive domains affected by cerebral malaria and severe malarial anemia in children. Learn Individ Differ (2015) 0.77
Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection. Parasitol Res (2013) 0.77
The relationship between visual-spatial and auditory-verbal working memory span in Senegalese and Ugandan children. PLoS One (2010) 0.77
Cerebral malaria is associated with long-term mental health disorders: a cross sectional survey of a long-term cohort. Malar J (2016) 0.76
Early prediction of cerebral malaria by (1)H NMR based metabolomics. Malar J (2016) 0.76
Thrombocytopenia May Mediate Disease Severity in Plasmodium falciparum Malaria Through Reduced Transforming Growth Factor Beta-1 Regulation of Proinflammatory and Anti-inflammatory Cytokines. Pediatr Infect Dis J (2015) 0.76
Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria. Open Forum Infect Dis (2016) 0.75
A Hospital-Based Retrospective Comparative Study of Complications, Outcomes, Clinical and Laboratory Parameters of Malaria with and without Neurological Involvement. Mediterr J Hematol Infect Dis (2017) 0.75
Changes Related to Age in Natural and Acquired Systemic Self-IgG Responses in Malaria. Interdiscip Perspect Infect Dis (2011) 0.75
The endothelial protein C receptor rs867186-GG genotype is associated with increased soluble EPCR and could mediate protection against severe malaria. Sci Rep (2016) 0.75
Exploring neurodevelopmental outcome measures used in children with cerebral malaria: the perspectives of caregivers and health workers in Malawi. BMC Pediatr (2017) 0.75
A quantitative brain map of experimental cerebral malaria pathology. PLoS Pathog (2017) 0.75
Validation of the CogState battery for rapid neurocognitive assessment in Ugandan school age children. Child Adolesc Psychiatry Ment Health (2015) 0.75
Longitudinal Visuomotor Development in a Malaria Endemic Area: Cerebral Malaria and Beyond. PLoS One (2016) 0.75
Cognitive Outcomes and Psychiatric Symptoms of Retinopathy-Positive Cerebral Malaria: Cohort Description and Baseline Results. Am J Trop Med Hyg (2017) 0.75
IL-33 receptor ST2 regulates the cognitive impairments associated with experimental cerebral malaria. PLoS Pathog (2017) 0.75
A Neuroprotective Effect of the Glutamate Receptor Antagonist MK801 on Long-Term Cognitive and Behavioral Outcomes Secondary to Experimental Cerebral Malaria. Mol Neurobiol (2016) 0.75
Cytokines and Chemokines in Cerebral Malaria Pathogenesis. Front Cell Infect Microbiol (2017) 0.75
Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol (2004) 6.89
Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg (2001) 4.83
Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther (1998) 3.57
Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol (2005) 3.54
Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry (2005) 3.28
Increased brain activity in frontal and parietal cortex underlies the development of visuospatial working memory capacity during childhood. J Cogn Neurosci (2002) 2.89
Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics (2007) 2.47
Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg (2000) 2.20
Developmental impairments following severe falciparum malaria in children. Trop Med Int Health (2005) 2.13
Immunopathogenesis of cerebral malaria. Int J Parasitol (2006) 2.08
Effects of early cerebral malaria on cognitive ability in Senegalese children. J Dev Behav Pediatr (2002) 2.02
Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch Dis Child (2005) 1.85
Residual neurologic sequelae after childhood cerebral malaria. J Pediatr (1997) 1.84
Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69
Neuro-cognitive impairment following acquired central nervous system infections in childhood: a systematic review. Brain Res Brain Res Rev (2003) 1.52
Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect Immun (1997) 1.36
High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol (2005) 1.34
Early activation of microglia in the pathogenesis of fatal murine cerebral malaria. Glia (1997) 1.32
Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol (2006) 1.32
Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase-3 and ultrastructural alterations in different disease stages. Neuropathol Appl Neurobiol (2007) 1.28
The cerebral-malaria-associated expression of RANTES, CCR3 and CCR5 in post-mortem tissue samples. Ann Trop Med Parasitol (2004) 1.25
Expression microarray analysis implicates apoptosis and interferon-responsive mechanisms in susceptibility to experimental cerebral malaria. Am J Pathol (2007) 1.20
Somatosensory discrimination deficits following pediatric cerebral malaria. Am J Trop Med Hyg (1998) 1.17
MR imaging of cerebral malaria in a child. Eur J Radiol (2006) 1.07
Evidence of brain dysfunction in attention deficit-hyperactivity disorder: a controlled study with proton magnetic resonance spectroscopy. Acad Radiol (2007) 0.90
Mortality after fluid bolus in African children with severe infection. N Engl J Med (2011) 10.99
Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics (2007) 2.47
Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer Cell (2008) 2.35
A statistical method for identifying differential gene-gene co-expression patterns. Bioinformatics (2004) 2.23
Can erythropoietin be used to prevent brain damage in cerebral malaria? Trends Parasitol (2008) 2.19
Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J (2009) 2.19
Information assessment on predicting protein-protein interactions. BMC Bioinformatics (2004) 2.14
WHO guidelines on fluid resuscitation in children: missing the FEAST data. BMJ (2014) 2.00
Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis (2012) 1.97
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children. PLoS One (2009) 1.93
Racial/Ethnic disparities in the use of nicotine replacement therapy and quit ratios in lifetime smokers ages 25 to 44 years. Cancer Epidemiol Biomarkers Prev (2008) 1.87
Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis (2006) 1.79
Thoracoscopic versus thoracotomy approaches to lobectomy: differential impairment of cellular immunity. Ann Thorac Surg (2008) 1.77
Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg (2008) 1.69
Rectal versus intravenous quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomized, double-blind clinical trial. Clin Infect Dis (2007) 1.65
Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children. Pediatrics (2006) 1.58
Mining the structural genomics pipeline: identification of protein properties that affect high-throughput experimental analysis. J Mol Biol (2004) 1.57
Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med (2013) 1.57
Incidence and outcome of convulsive status epilepticus in Kenyan children: a cohort study. Lancet Neurol (2008) 1.55
Volume expansion with albumin compared to gelofusine in children with severe malaria: results of a controlled trial. PLoS Clin Trials (2006) 1.55
High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci U S A (2008) 1.54
A role for MEIS1 in MLL-fusion gene leukemia. Blood (2008) 1.52
Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett (2011) 1.43
Detection of DNA copy number alterations using penalized least squares regression. Bioinformatics (2005) 1.38
Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res Notes (2010) 1.37
Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment. PLoS Comput Biol (2013) 1.34
Inpatient mortality in children with clinically diagnosed malaria as compared with microscopically confirmed malaria. Pediatr Infect Dis J (2008) 1.33
Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis (2008) 1.32
Nodding syndrome in Ugandan children--clinical features, brain imaging and complications: a case series. BMJ Open (2013) 1.29
Socioeconomic predictors of cognition in Ugandan children: implications for community interventions. PLoS One (2009) 1.25
Immediate neuropsychological and behavioral benefits of computerized cognitive rehabilitation in Ugandan pediatric cerebral malaria survivors. J Dev Behav Pediatr (2009) 1.23
Comparison of buccal midazolam with rectal diazepam in the treatment of prolonged seizures in Ugandan children: a randomized clinical trial. Pediatrics (2008) 1.23
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria. Expert Rev Anti Infect Ther (2010) 1.20
Survival and haematological recovery of children with severe malaria transfused in accordance to WHO guidelines in Kilifi, Kenya. Malar J (2008) 1.19
Genetic diversity of Plasmodium falciparum infections in mild and severe malaria of children from Kampala, Uganda. Parasitol Res (2013) 1.18
HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS (2010) 1.16
Detecting and aligning peaks in mass spectrometry data with applications to MALDI. Comput Biol Chem (2005) 1.13
Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease. Cytokine (2008) 1.12
Pesticide exposure and neurodevelopmental outcomes: review of the epidemiologic and animal studies. J Toxicol Environ Health B Crit Rev (2013) 1.12
1-naphthylpropargyl ether group: a readily cleaved and sterically minimal protecting system for stereoselective glycosylation. Org Lett (2006) 1.10
A pilot study of the neuropsychological benefits of computerized cognitive rehabilitation in Ugandan children with HIV. Neuropsychology (2010) 1.09
The association between atopy and childhood/adolescent leukemia: a meta-analysis. Am J Epidemiol (2010) 1.09
The inborn errors of metabolism information system: A project of the Region 4 Genetics Collaborative Priority 2 Workgroup. Genet Med (2010) 1.07
Use of a three-band HRP2/pLDH combination rapid diagnostic test increases diagnostic specificity for falciparum malaria in Ugandan children. Malar J (2014) 1.07
Continuous EEG monitoring in Kenyan children with non-traumatic coma. Arch Dis Child (2012) 1.06
Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials (2011) 1.06
NeuroAIDS in Africa. J Neurovirol (2010) 1.05
Multiple peak alignment in sequential data analysis: a scale-space-based approach. IEEE/ACM Trans Comput Biol Bioinform (2006) 1.03
Detection of cytomegalovirus DNA in dried blood spots of Minnesota infants who do not pass newborn hearing screening. Pediatr Infect Dis J (2009) 1.03
Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness. BMC Med (2015) 1.02
Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast. Brain (2011) 1.01
Rehabilitation for cognitive impairments after cerebral malaria in African children: strategies and limitations. Trop Med Int Health (2006) 1.01
Enzymatic synthesis of UDP-GlcNAc/UDP-GalNAc analogs using N-acetylglucosamine 1-phosphate uridyltransferase (GlmU). Chem Commun (Camb) (2009) 1.01
Malaria with neurological involvement in Ugandan children: effect on cognitive ability, academic achievement and behaviour. Malar J (2011) 1.00
Impaired everyday memory associated with encephalopathy of severe malaria: the role of seizures and hippocampal damage. Malar J (2009) 1.00
TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg (2010) 1.00
Stereoselective iterative one-pot synthesis of N-glycolylneuraminic acid-containing oligosaccharides. Org Lett (2008) 0.99
Defining function of lipopolysaccharide O-antigen ligase WaaL using chemoenzymatically synthesized substrates. J Biol Chem (2011) 0.98
Proteome of human calcium kidney stones. Urology (2010) 0.98
A year-long caregiver training program improves cognition in preschool Ugandan children with human immunodeficiency virus. J Pediatr (2013) 0.97
Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. PLoS One (2010) 0.97
A year-long caregiver training program to improve neurocognition in preschool Ugandan HIV-exposed children. J Dev Behav Pediatr (2013) 0.97
The tympanic membrane displacement analyser for monitoring intracranial pressure in children. Childs Nerv Syst (2013) 0.96
Reliability of the Luganda version of the Child Behaviour Checklist in measuring behavioural problems after cerebral malaria. Child Adolesc Psychiatry Ment Health (2009) 0.96
Robust and efficient identification of biomarkers by classifying features on graphs. Bioinformatics (2008) 0.95
var gene transcription dynamics in Plasmodium falciparum patient isolates. Mol Biochem Parasitol (2009) 0.95
Stereocontrolled synthesis of mannans and rhamnans. Adv Carbohydr Chem Biochem (2009) 0.95
Slow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011-2013. Emerg Infect Dis (2015) 0.94
Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria. J Neurol Sci (2007) 0.94
Convergent synthesis of a beta-(1-->3)-mannohexaose. J Org Chem (2007) 0.93
A high productivity/low maintenance approach to high-performance computation for biomedicine: four case studies. J Am Med Inform Assoc (2004) 0.92
Global NeuroAIDS roundtable. J Neurovirol (2013) 0.92
Phase III trials required to resolve clinical equipoise over optimal fluid management in children with severe malaria. PLoS Clin Trials (2007) 0.91
Neonatal seizures in a rural Kenyan District Hospital: aetiology, incidence and outcome of hospitalization. BMC Med (2010) 0.91
Meis1 maintains stemness signature in MLL-AF9 leukemia. Blood (2010) 0.91
Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control study. BMC Pediatr (2011) 0.91
Evaluation of newborn screening bloodspot-based genetic testing as second tier screen for bedside newborn hearing screening. Genet Med (2011) 0.90